HCW Biologics HCWB Stock
HCW Biologics Price Chart
HCW Biologics HCWB Financial and Trading Overview
| HCW Biologics stock price | 7.4 USD |
| Previous Close | 2.09 USD |
| Open | 2.15 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1000 |
| Day's Range | 2.07 - 2.15 USD |
| 52 Week Range | 1.08 - 2.79 USD |
| Volume | 12.24K USD |
| Avg. Volume | 19.19K USD |
| Market Cap | 76.44M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -30.8 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
HCWB Valuation Measures
| Enterprise Value | 53.2M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.2272727 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 20.963434 |
| Price/Book (mrq) | 2.3432345 |
| Enterprise Value/Revenue | 14.589 |
| Enterprise Value/EBITDA | -3.008 |
Trading Information
HCW Biologics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 2.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.79 USD |
| 52 Week Low | 1.08 USD |
| 50-Day Moving Average | 1.57 USD |
| 200-Day Moving Average | 1.93 USD |
HCWB Share Statistics
| Avg. Volume (3 month) | 19.19K USD |
| Avg. Daily Volume (10-Days) | 43.51K USD |
| Shares Outstanding | 35.89M |
| Float | 17.77M |
| Short Ratio | 0.65 |
| % Held by Insiders | 59.75% |
| % Held by Institutions | 2.18% |
| Shares Short | 12.96K |
| Short % of Float | 0.069% |
| Short % of Shares Outstanding | 0.040% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -508.95% |
| Gross Margin | 22.19% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.55% |
| Return on Equity (ttm) | -43.68% |
Income Statement
| Revenue (ttm) | 3.65M USD |
| Revenue Per Share (ttm) | 0.1 USD |
| Quarterly Revenue Growth (yoy) | -98.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | -17684622 USD |
| Net Income Avi to Common (ttm) | -17914182 USD |
| Diluted EPS (ttm) | -0.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 28.24M USD |
| Total Cash Per Share (mrq) | 0.79 USD |
| Total Debt (mrq) | 6.61M USD |
| Total Debt/Equity (mrq) | 20.26 USD |
| Current Ratio (mrq) | 6.621 |
| Book Value Per Share (mrq) | 0.909 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12432161 USD |
| Levered Free Cash Flow (ttm) | -16121135 USD |
Profile of HCW Biologics
| Country | United States |
| State | FL |
| City | Miramar |
| Address | 2929 North Commerce Parkway |
| ZIP | 33025 |
| Phone | 954 842 2024 |
| Website | https://www.hcwbiologics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 44 |
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Q&A For HCW Biologics Stock
What is a current HCWB stock price?
HCW Biologics HCWB stock price today per share is 7.4 USD.
How to purchase HCW Biologics stock?
You can buy HCWB shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HCW Biologics?
The stock symbol or ticker of HCW Biologics is HCWB.
Which industry does the HCW Biologics company belong to?
The HCW Biologics industry is Biotechnology.
How many shares does HCW Biologics have in circulation?
The max supply of HCW Biologics shares is 1.12M.
What is HCW Biologics Price to Earnings Ratio (PE Ratio)?
HCW Biologics PE Ratio is now.
What was HCW Biologics earnings per share over the trailing 12 months (TTM)?
HCW Biologics EPS is -30.8 USD over the trailing 12 months.
Which sector does the HCW Biologics company belong to?
The HCW Biologics sector is Healthcare.
HCW Biologics HCWB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Global Market Composite NQGM | 1849.42 USD — |
-0.28
|
— — | 1847.45 USD — | 1856.63 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.86 USD — |
-0.77
|
— — | 922.17 USD — | 926.68 USD — | — - | — — |
- {{ link.label }} {{link}}